The drug firm reported ₹439.7 crore in revenue, down 10.5% on a year-on-year basis and 14.8% on sequential basis. Revenue in the same quarter last year stood at ₹398 crore while previous quarter reported ₹516 crore.
The drug firm reported ₹439.7 crore in revenue, down 10.5% on a year-on-year basis and 14.8% on sequential basis. Revenue in the same quarter last year stood at ₹398 crore while previous quarter reported ₹516 crore.